Company overview
Basic information
Company name
Film doctor, MB
Company code
306671938
VAT code
LT100017036612
Registered address
Vilnius, Santariškių g. 75-34, LT-08457
Registration date
2024-01-30
Company age: 2 y. 8 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Motion picture, video and television programme production activities
Ownership form
Private without foreign capital
MB Film doctor
Company code: 306671938
Address: Vilnius, Santariškių g. 75-34, LT-08457
VAT code: LT100017036612
Download a detailed company report
Make confident decisions with all the information about Film doctor, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Film doctor, MB (company code 306671938) is a private small partnership registered on 30 January 2024 and currently operational. It is classified as a micro company in the national private non-financial companies sector and operates under private ownership, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. Governance is listed as CEO only. The company is based in Vilnius, Vilniaus m. sav., Vilniaus apskr.
Its EVRK activity is J.59.11.00, Motion picture, video and television programme production activities. In financial year 2025, the company generated EUR 97.0K in revenue, up from EUR 39.0K in 2024, and increased net profit to EUR 16.0K from EUR 2.0K a year earlier. The 2025 profit margin was 16.5%. At year-end 2025, equity stood at EUR 17.0K, liabilities at EUR 2.0K, and total assets at EUR 19.0K. Staff reporting is tracked so far in 2026.
Its EVRK activity is J.59.11.00, Motion picture, video and television programme production activities. In financial year 2025, the company generated EUR 97.0K in revenue, up from EUR 39.0K in 2024, and increased net profit to EUR 16.0K from EUR 2.0K a year earlier. The 2025 profit margin was 16.5%. At year-end 2025, equity stood at EUR 17.0K, liabilities at EUR 2.0K, and total assets at EUR 19.0K. Staff reporting is tracked so far in 2026.